Biofabri appoints Rolando Pajón to strengthen the late-stage development of its Tuberculosis Vaccine Candidate
Biofabri appoints Rolando Pajón to strengthen the late-stage development of its Tuberculosis Vaccine Candidate The appointment comes at a key stage of the project, as MTBVAC advances toward the final phases of clinical development. The move is part of Biofabri’s strategy to strengthen its pipeline of innovative medicines aimed at addressing major global health challenges. […]
Consultation meeting advances the renewed TB Vaccine Development Pathway
On 12 February 2026, an open online consultation meeting on the TB Vaccine Development Pathway brought together experts and stakeholders to review its recent renewal and gather input for further improvements. This consultation supports coordinated global efforts to accelerate TB vaccine development and improve future access and implementation of TB vaccines for all. TB Vaccine […]
Call for Early Career Researchers to join the CTVD meeting
Call for Early Career Researchers to join the CTVD meeting The 2026 Collaboration for TB Vaccine Discover (CTVD) Annual Meeting will take place in Nairobi, Kenya June 8-11, 2026. As in years past, CTVD will be offering travel awards for ~30 Early Career Researchers (ECRs) to attend the meeting and present a poster. ECRs will […]
Fourth call for applications to assess efficacy of Mycobacterium tuberculosis vaccine candidates
Diversifying the vaccine development pipeline has been recognized as a priority in the Global TB Vaccine R&D Roadmap. The TBVAC-HORIZON consortium has successfully secured funding for an ambitious four-year project that aims to fill the early stages of the development pipeline while ensuring a diverse portfolio of vaccine candidates (TBVAC-HORIZON – TBVI). One of the key […]
Open online consultation workshop on the renewed TB Vaccine Development Pathway – 12 February 2026
To diversify the TB Vaccine pipeline and accelerate TB Vaccine development, scientific innovations are crucial. Both successful new approaches and unexpected negative results need to be communicated widely to enable effective implementation in future R&D. For that reason, TBVI brought together two working groups of preclinical and clinical experts to evaluate recent scientific progress and […]
8th Global Forum for TB Vaccines to be held in April 2027 in Zaragoza, Spain
8th Global Forum for TB Vaccines to be held in April 2027 in Zaragoza, Spain The University of Zaragoza has announced in a press release that it will host the next edition of the Forum. Read the full article here.
WHO launches the Global TB Report 2025
WHO launches the Global TB Report 2025 The World Health Organization (WHO) has released the Global Tuberculosis (TB) Report 2025. This report offers a thorough and current evaluation of the TB epidemic, as well as progress made in preventing, diagnosing, and treating the disease at global, regional, and country levels. This is done in the […]
Announcement Awardees | TBVI Awards 2026
Announcement Awardees | TBVI Awards 2026 The TBVI Award aims to encourage promising scientists by recognising their outstanding contributions to tuberculosis (TB) vaccine research and development. It offers them a platform to showcase their work at the TBVI symposium, taking place on January 27-28, 2026, in the picturesque Les Diablerets, Switzerland. This annual meeting is […]
Phase 1b/2a clinical trial in adults of novel TB vaccine candidate MTBVAC shows promising results
MTBVAC caused similar or stronger immune responses compared to the Bacille Calmette-Guérin (BCG) vaccine. NEW YORK, USA, PORRIÑO, SPAIN, CAPE TOWN, SOUTH AFRICA – April 22, 2025 – IAVI, Biofabri, the University of Zaragoza (UNIZAR), and the South African Tuberculosis Vaccine Initiative (SATVI) are pleased to announce today promising results from the IAVI-sponsored A-050 […]
Announcement TBVI Awards 2026
Would you like to present your work at the TBVI Annual Symposium? To encourage promising scientists and recognise outstanding contributions to TB vaccine research and development, TBVI presents the TBVI Awards. Promising scientists are given the opportunity to give a 15-minute presentation about their work during the annual TBVI symposium where researchers, policymakers, and funders […]